SMIM1 gene

Known as: Vel, small integral membrane protein 1 (Vel blood group), SMIM1 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2017
012320092017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
CONCLUSIONS The blood group antigen Vel has been one of immunohematology's greatest enigmas: the variation in antigen strength… (More)
Is this relevant?
2017
2017
Preclinical characterization of velpatasvir (VEL; GS-5816), an inhibitor of the hepatitis C virus (HCV) NS5A protein… (More)
  • table 2
  • table 1
  • table 3
  • table 4
  • table 5
Is this relevant?
2017
2017
OBJECTIVE To analyze an individual with SMIM1 c.64_80 heterozygous deletional mutation and his family members. METHODS Based on… (More)
Is this relevant?
2016
2016
Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with… (More)
Is this relevant?
2016
2016
BACKGROUND AND OBJECTIVES The Vel blood group antigen is a poorly characterized high-prevalence antigen. Until now, anti-Vel… (More)
  • table 1
  • figure 1
  • figure 3
Is this relevant?
2015
2015
Disruption of SMIM1, encoding small integral membrane protein 1, is responsible for the Vel-negative blood type, a rare but… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Here, we report the biochemical and genetic basis of the Vel blood group antigen, which has been a vexing mystery for decades… (More)
Is this relevant?
2013
2013
The Vel antigen is present on red blood cells (RBCs) from all humans except rare Vel-negative individuals who can form antibodies… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
We build a stochastic model to analyze the dynamics of HIV in a homosexually active population. In our model, we introduce the… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
2009
2009
The population vaccination effectiveness (PVE) is defined as the fraction of disease cases prevented by a vaccination campaign… (More)
  • figure 1
  • figure 2
Is this relevant?